← SynDRA
TAS-106
SynDRA canonical compound SYN0020125 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Mechanism of action | antimetabolite |
All known targets
Mechanisms of action (all sources)
- POLR1A INHIBITOR
- DNA-directed RNA polymerase I subunit RPA1 inhibitor
- POLR2A INHIBITOR
- DNA-directed RNA polymerase II subunit RPB1 inhibitor
- POLR3A INHIBITOR
- DNA-directed RNA polymerase III subunit RPC1 inhibitor
Cross-references
Synonyms
- 2'-c-ethynylcytidine
- 3'-c-ethynylcytidine
- 3'-C-Ethynylcytidine
- ECyd
- Y3O05I09ZK
- 1-(3-C-Ethynyl-beta-D-ribo-pentofuranosyl)cytosine
- RefChem:187470
- ethynylcytidine
- cytidine, 3'-c-ethynyl-
- MFCD00942308
- UNII-Y3O05I09ZK
- NSC722662
- ECyD;TAS-106;3'-C-Ethynylcytidine
- 3'-ethynylcytidine
- SCHEMBL543763
- TAS 106 [WHO-DD]
- CHEBI:231178
- JFIWEPHGRUDAJN-DYUFWOLASA-N
- GLXC-05245
- ECyD;TAS-106;3-C-Ethynylcytidine
- AKOS025290187
- AS-35187
- DA-63311
- HY-16200
- SY378775
- CS-0006185
- NS00069264
- 1-(3-C-ETHYNYL-.BETA.-D-RIBO-PENTOFURANOSYL)CYTOSINE
- 4-Amino-1-((2R,3R,4R,5R)-4-ethynyl-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)pyrimidin-2-one
Look up TAS-106 in the interactive SynDRA portal →